Prudential Financial’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.08M | Sell |
610,452
-58,337
| -9% | -$294K | ﹤0.01% | 1167 |
|
|
2025
Q1 | $4.33M | Buy |
668,789
+424,220
| +173% | +$2.75M | 0.01% | 906 |
|
|
2024
Q4 | $1.8M | Sell |
244,569
-180,800
| -43% | -$1.33M | ﹤0.01% | 1342 |
|
|
2024
Q3 | $3.19M | Buy |
425,369
+134,300
| +46% | +$1.01M | ﹤0.01% | 1221 |
|
|
2024
Q2 | $2.59M | Buy |
291,069
+148,340
| +104% | +$1.32M | ﹤0.01% | 1280 |
|
|
2024
Q1 | $1.45M | Sell |
142,729
-322,760
| -69% | -$3.27M | ﹤0.01% | 1633 |
|
|
2023
Q4 | $4.68M | Buy |
465,489
+153,420
| +49% | +$1.54M | 0.01% | 963 |
|
|
2023
Q3 | $2.92M | Buy |
312,069
+99,655
| +47% | +$934K | ﹤0.01% | 1156 |
|
|
2023
Q2 | $5.21M | Sell |
212,414
-6,638
| -3% | -$163K | 0.01% | 883 |
|
|
2023
Q1 | $5.1M | Sell |
219,052
-39,170
| -15% | -$911K | 0.01% | 865 |
|
|
2022
Q4 | $6.54M | Sell |
258,222
-2,495
| -1% | -$63.1K | 0.01% | 769 |
|
|
2022
Q3 | $5.03M | Buy |
260,717
+114,505
| +78% | +$2.21M | 0.01% | 881 |
|
|
2022
Q2 | $3.72M | Buy |
146,212
+82,555
| +130% | +$2.1M | 0.01% | 1045 |
|
|
2022
Q1 | $1.64M | Buy |
63,657
+52,882
| +491% | +$1.36M | ﹤0.01% | 1621 |
|
|
2021
Q4 | $451K | Buy |
10,775
+4,420
| +70% | +$185K | ﹤0.01% | 2240 |
|
|
2021
Q3 | $277K | Buy |
6,355
+1,530
| +32% | +$66.7K | ﹤0.01% | 2355 |
|
|
2021
Q2 | $228K | Buy |
4,825
+260
| +6% | +$12.3K | ﹤0.01% | 2414 |
|
|
2021
Q1 | $234K | Buy |
+4,565
| New | +$234K | ﹤0.01% | 2359 |
|